R. Nosal

PQLI Key Topics - Criticality, Design Space, and Control Strategy

Roger Nosal, Graham Cook, Thomas Garcia, 2008, Journal of Pharmaceutical Innovation.

API Quality by Design Example from the Torcetrapib Manufacturing Process

Roger Nosal, Jason Mustakis, Timothy J. N. Watson, 2007, Journal of Pharmaceutical Innovation.

The Application of Science- and Risk-Based Concepts to Drug Substance Stability Strategies

Roger Nosal, Stephen T. Colgan, Timothy J. Watson, 2012, Journal of Pharmaceutical Innovation.

Cluster of cases of Creutzfeldt-Jakob disease--Ontario.

R Nosal, A Kapoor, R Shanin, 1991, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada.

Advancing Product Quality: a Summary of the Second FDA/PQRI Conference

G. K. Raju, Lawrence X. Yu, Larisa C Wu, 2016, The AAPS Journal.

The Selection and Control of Starting Materials Should be Governed by Science and Risk-Based Approaches

Roger Nosal, Timothy J. N. Watson, Frank Montgomery, 2016, The AAPS Journal.

PQLI Definition of Criticality

Roger Nosal, Tom Schultz, R. Nosal, 2008, Journal of Pharmaceutical Innovation.

SCIENTIFIC OPPORTUNITIES THROUGH QUALITY BY DESIGN

Roger Nosal, Timothy J. N. Watson, R. Nosal, 2010, Chemical Engineering in the Pharmaceutical Industry.